Herbal Medicines for the Treatment of Chronic Obstructive Airway Diseases (Asthma or Chronic Obstructive Pulmonary Disease): A Prospective Observational Study
Table 3
Pulmonary function tests and PEFR before and after herbal medicine treatments.
Total (n = 24)
Asthma (n = 14)
COPD (n = 10)
FVC
Baseline
86.42 (78.08, 94.76)
88.00 (78.18, 97.82)
84.20 (67.13, 101.27)
Week 12
86.72 (76.543, 96.89)
88.00 (76.75, 99.24)
84.93 (65.62, 104.23)
value
0.9326
0.9994
0.8227
FEV1
Baseline
73.92 (64.26, 83.57)
79.93 (67.72, 92.14)
65.50 (48.63, 82.37)
Week 12
71.61 (60.67, 82.55)
77.68 (64.08, 91.27)
63.11 (47.41, 78.80)
value
0.5987
0.7383
0.4743
FEV1/FVC
Baseline
62.13 (56.32, 67.93)
67.29 (61.37, 73.21)
54.90 (44.00, 65.80)
Week 12
60.30 (53.83, 66.77)
65.50 (57.98, 73.03)
53.02 (42.92, 63.12)
value
0.3256
0.5021
0.4523
PEFR
Baseline
255.0 (209.7, 300.3)
286.4 (224.4, 348.5)
211.0 (143.1, 278.9)
Week 4
254.0 (212.5, 295.5)
280.4 (219.3, 341.4)
217.0 (165.2, 268.8)
value
0.9424
0.7959
0.6327
Week 8
263.0 (226.3, 299.8)
293.8 (243.7, 343.9)
220.0 (170.4, 269.6)
value
0.5750
0.7362
0.6099
Week 12
256.2 (218.6, 293.9)
276.4 (220.4, 332.3)
228.1 (187.5, 268.7)
value
0.9305
0.6451
0.2201
Data are presented as mean (95% CI). value by paired t-test.
